|Bid||42.59 x 800|
|Ask||67.50 x 1100|
|Day's Range||61.39 - 62.28|
|52 Week Range||33.41 - 68.24|
|Beta (5Y Monthly)||0.99|
|PE Ratio (TTM)||60.91|
|Earnings Date||May 05, 2021 - May 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||71.47|
In this article we are going to estimate the intrinsic value of Globus Medical, Inc. ( NYSE:GMED ) by taking the...
GMED earnings call for the period ending December 31, 2020.
Shares of Globus Medical (NYSE:GMED) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 18.37% over the past year to $0.58, which beat the estimate of $0.51. Revenue of $233,445,000 higher by 10.29% from the same period last year, which beat the estimate of $231,220,000. Guidance The upcoming fiscal year's EPS expected to be between $1.83 and $1.83. The upcoming fiscal year's revenue expected to be between $880,000,000 and $880,000,000. Conference Call Details Date: Feb 17, 2021 View more earnings on GMED Time: 04:30 PM ET Webcast URL: https://edge.media-server.com/mmc/p/8oo77asj Price Action 52-week high: $68.24 52-week low: $33.41 Price action over last quarter: Up 27.16% Company Description Globus Medical is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which includes medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which includes advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. See more from BenzingaClick here for options trades from BenzingaEarnings Scheduled For February 17, 2021© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.